These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34035288)

  • 1. Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.
    Kastan N; Gnedeva K; Alisch T; Petelski AA; Huggins DJ; Chiaravalli J; Aharanov A; Shakked A; Tzahor E; Nagiel A; Segil N; Hudspeth AJ
    Nat Commun; 2021 May; 12(1):3100. PubMed ID: 34035288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP Mediates Hair Cell Regeneration in Balance Organs of Chickens, But LATS Kinases Suppress Its Activity in Mice.
    Rudolf MA; Andreeva A; Kozlowski MM; Kim CE; Moskowitz BA; Anaya-Rocha A; Kelley MW; Corwin JT
    J Neurosci; 2020 May; 40(20):3915-3932. PubMed ID: 32341094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
    Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs.
    Kastan NR; Oak S; Liang R; Baxt L; Myers RW; Ginn J; Liverton N; Huggins DJ; Pichardo J; Paul M; Carroll TS; Nagiel A; Gnedeva K; Hudspeth AJ
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2206113119. PubMed ID: 35867764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.
    Bao Y; Nakagawa K; Yang Z; Ikeda M; Withanage K; Ishigami-Yuasa M; Okuno Y; Hata S; Nishina H; Hata Y
    J Biochem; 2011 Aug; 150(2):199-208. PubMed ID: 21586534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of YAP by mechanical strain through Jnk and Hippo signaling.
    Codelia VA; Sun G; Irvine KD
    Curr Biol; 2014 Sep; 24(17):2012-7. PubMed ID: 25127217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Pathway Blocks Mammalian Retinal Müller Glial Cell Reprogramming.
    Rueda EM; Hall BM; Hill MC; Swinton PG; Tong X; Martin JF; Poché RA
    Cell Rep; 2019 May; 27(6):1637-1649.e6. PubMed ID: 31067451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.
    Xiao L; Chen Y; Ji M; Dong J
    J Biol Chem; 2011 Mar; 286(10):7788-7796. PubMed ID: 21233212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
    Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
    Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
    Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo pathway effector Yap promotes cardiac regeneration.
    Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.